Table 1.
Demographics
| Demographics | Oritavancin | Vancomycin | P Value |
|---|---|---|---|
| N = 120 | N = 6695 | ||
| Age (mean, SD) | 54.9 (16.8) | 52.8 (16.5) | .18 |
| Age group (N, %) | .66 | ||
| 18–34 | 16 (13.3%) | 993 (14.8%) | |
| 35–44 | 12 (10%) | 962 (14.4%) | |
| 45–54 | 29 (24.2%) | 1523 (22.7%) | |
| 55–64 | 39 (32.5%) | 1941 (29.0%) | |
| 65+ | 24 (20%) | 1276 (19.1%) | |
| Sex (%, N) | .71 | ||
| Male | 68 (56.7%) | 3680 (55.0%) | |
| Female | 52 (43.3%) | 3015 (45.0%) | |
| Insurance plan type (N, %) | .018 | ||
| Comprehensive/indemnity | 12 (10%) | 930 (13.9%) | |
| EPO/PPO | 67 (55.8%) | 3506 (52.4%) | |
| POS/POS with capitation | 19 (15.8%) | 572 (8.5%) | |
| HMO | 5 (4.2%) | 590 (8.8%) | |
| CDHP/HDHP | 17 (14.2%) | 987 (14.7%) | |
| Unknown | 0 (0%) | 110 (1.6%) | |
| Primary payer(%) | .54 | ||
| Commercial | 93 (77.5%) | 5339 (79.7%) | |
| Medicare | 27 (22.5%) | 1356 (20.3%) | |
| Geographic region | .001 | ||
| Northeast | 10 (8.3%) | 765 (11.4%) | |
| North Central | 19 (15.8%) | 1721 (25.7%) | |
| South | 82 (68.3%) | 3347 (50%) | |
| West | 8 (6.7%) | 846 (12.6%) | |
| Unknown | 1 (0.8%) | 16 (0.2%) | |
| Population density | .28 | ||
| Urban | 97 (80.8%) | 5635 (84.2%) | |
| Rural | 22 (18.3%) | 1045 (15.6%) | |
| Unknown | 1 (0.8%) | 15 (0.2%) | |
| Index month (N, %) | .22 | ||
| January 2016 | 5 (4.2%) | 721 (10.8%) | |
| February 2016 | 9 (7.5%) | 537 (8.0%) | |
| March 2016 | 16 (13.3%) | 635 (9.5%) | |
| April 2016 | 15 (12.5%) | 582 (8.7%) | |
| May 2016 | 14 (11.7%) | 637 (9.5%) | |
| June 2016 | 14 (11.7%) | 671 (10.0%) | |
| July 2016 | 10 (8.3%) | 841 (12.6%) | |
| August 2016 | 16 (13.3%) | 733 (10.9%) | |
| September 2016 | 9 (7.5%) | 674 (10.1%) | |
| October 2016 | 12 (10.0%) | 635 (9.5%) |
Abbreviations: CDHP, consumer-driven healthplan; EPO, exclusive provider organization; HDHP, high deductible healthplan; HMO, health maintenance organization; POS, point-of-service; PPO, preferred provider organization; SD, standard deviation.